Member access

4-Traders Homepage  >  Shares  >  SHENZHEN STOCK EXCHANGE  >  Beijing SL Pharmaceutical Co Ltd    002038   CNE000001L31

No quotes available
-- CNY   --.--%
2014 BEIJING SL PHAR : H1 Net Up 22%
2014 BEIJING SL PHAR : SL Pharmaceutical 2013 Net Up 20.04%
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Produces and supplies pharmaceutical products

Beijing SL Pharmaceutical Co. Ltd. engages in the development and marketing gene engineering drugs.

Its products include Li Sheng Su, a recombinant human Granulocyte Colony-stimulating Factor (rhG-CSF) injection; Mai Ge Er, a recombinant human Interleukin-11 (rhIL-11) injection; and Xin Ji Er, a recombinant human Ala Interleukin-2 (Ala IL-2) injection.

The company was founded by Ming Bo Xu in December 1994 and is headquartered in Beijing, China.

Number of employees : 637 persons.
Sales per Businesses
20122013Delta
CNY (in Million)%CNY (in Million)%
Biochemical Medicine822.9081.8%981.0284.5% +16.12%
Chemistry Medicine128.9412.8%131.5311.3% +1.97%
Other Service Income55.185.5%35.003% -57.68%
Other--14.231.2%-
Sales per Regions
20122013Delta
CNY (in Million)%CNY (in Million)%
China1,006100%1,161100% +13.33%
Managers
NameAgeSinceTitle
Mingbo Xu, PhD50-Chairman & President
Anjing Lu57-Chairman-Supervisory Board
Wenying Xi51-Chief Financial Officer
Yu Lin Chen69-Director
Xiu Jiang Wen37-Director-Supervisory Board
Qing Jun Ma78-Independent Director
Su Yan Wei, CPA62-Independent Director
Ming Xi Zhang, CPA442007Independent Director
Shujie Liang48-Board Secretary
Yong Bo Wang39-Vice President
Shareholders
NameShares%
Xinxiang State Owned Asset Sup. & Adm. Commssion 96,643,729 25.8%
Mingbo Xu, PhD 25,743,501 6.86%
China International Fund Management Co., Ltd. 12,095,889 3.23%
China Resources SZITIC Trust Co., Ltd. 10,100,044 2.69%
E Fund Management Co., Ltd. 8,950,669 2.39%
Harvest Fund Management Co., Ltd. 8,661,037 2.31%
Bin Wang 5,479,100 1.46%
Fortune SG Fund Management Co., Ltd. 5,398,144 1.44%
China Universal Asset Management Co., Ltd. 4,932,585 1.32%
Penghua Fund Management Co., Ltd. 4,880,220 1.30%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
ACTELION LTD
SHANGHAI RAAS BLO..
-
MEDIVATION INC
INTERCEPT PHARMAC..
GENMAB A/S
AGIOS PHARMACEUTI..
RECEPTOS INC
NEUROCRINE BIOSCI..
HUALAN BIOLOGICAL..
BEIJING SL PHARMA..
BLUEBIRD BIO INC
TONGHUA DONGBAO P..
MANNKIND CORPORAT..
CLOVIS ONCOLOGY I..
PTC THERAPEUTICS,..
DYAX CORP.
AUSPEX PHARMACEUT..
-
TESARO INC
INSYS THERAPEUTIC..
CHINA BIOLOGIC PR..
Sector Biotechnology & Medical Research
Company contact information
Beijing SL Pharmaceutical Co., Ltd.
9 Zhongyuan Road
Bada High Development District
Beijing 100041

Phone : +86.10.8879.9370
Fax : +86.10.8879.5883
Web : www.slpharm.com.cn
© 2015 Factset   
Dynamic quotes  
ON
| OFF